To determine whether RRM2 silencing could promote the infiltration of CD8 + T cells in TME, the C57BL/6 mouse model was used, and the results showed that RRM2 silencing increased the infiltration of CD8 + T cells in tumor tissues and spleens. Here, RRM2 is linked to neoplasm.